TP53 and osteosarcoma: Lycorine was reported to exhibit cytotoxic effects on human osteosarcoma cell-lines SJSA-1 and U2OS via inducing G1 phase cell cycle arrest and cellular apoptosis by activating p38 MAPK and p53-dependent apoptotic program (Ning et al., 2020).